- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Siemens gets nod for CT calcium scoring
Siemens Medical Systems has received 510(k) clearance for a calcium scoring software package for cardiac CT studies. The software is designed to help physicians determine a patient’s risk of future cardiac problems by analyzing the amount of calcium
Siemens Medical Systems has received 510(k) clearance for a calcium scoring software package for cardiac CT studies. The software is designed to help physicians determine a patients risk of future cardiac problems by analyzing the amount of calcium in the coronary arteries.
The software is included on Siemens 3-D Virtuoso postprocessing workstation, and works with data collected by the companys SubSecond Cardio CT scanning package (SCAN 4/29/99). The calcium scoring option enables radiologists to mark a region of interest and receive a calcium score for that area, using either Agatston or volume scores to measure the degree of calcification. The software also automatically creates reports for referring physicians, according to the company.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
